Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Marianne Mancini | Researchclopedia

Back to researchers

Marianne Mancini

Viking Therapeutics (United States)

9

Works

181

Citations

4

h-index

3

i10-index

Research Topics

Liver Disease Diagnosis and Treatment Treatment of Major Depression Immunodeficiency and Autoimmune Disorders

Affiliations

Eli Lilly (Singapore)2010–2010

Viking Therapeutics (United States)2025–2025

Baxter (United States)2005–2006

Top Works

LBP-20-VK2809, a Novel Liver-Directed Thyroid Receptor Beta Agonist, Significantly Reduces Liver Fat with Both Low and High Doses in Patients with Non-Alcoholic Fatty Liver Disease: A Phase 2 Randomized, Placebo-Controlled Trial

Rohit Loomba,Joel Neutel,et al.

201985 citations

Chronic Obstructive Pulmonary Disease (COPD) Research

Liver Disease and Transplantation

Efficacy, Safety and Tolerability of a New 10% Liquid Intravenous Immune Globulin [IGIV 10%] in Patients with Primary Immunodeficiency

Joseph A. Church,Heinz Leibl,et al.

200678 citations

Duloxetine versus venlafaxine in the treatment of unipolar and bipolar depression.

Gianluca Serafini,Maurizio Pompili,et al.

201010 citations

VK2809, a novel liver-directed thyroid receptor agonist, produces durable reductions in liver fat in patients with non-alcoholic fatty liver disease: results of 4-week follow-up assessment from a 12-week phase 2 randomized, placebo-controlled trial

Brian W. Lian,Rohit Loomba,et al.

20208 citations

A study to evaluate the safety, tolerability, processing by the body, and response of the body to the drug VK2735 in healthy adults

Marianne Mancini,Joel Neutel

20210 citations

P.2.c.008 Assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease

Marianne Mancini,G. Meco,et al.

20100 citations

Selection of the optimal nebulizer for further clinical development of inhaled nebulized nitrite (AIR001) in pulmonary arterial hypertension patients

Ed Parsley,Hiroko Masamune,et al.

20120 citations

CO107 Obesity Impact on Incidence of Chronic Comorbid Conditions

Karen Chung,Marianne Mancini,et al.

20250 citations

Efficacy, safety and tolerability of a new intravenous immune globulin, 10% liquid, triple virus reduced (IGIV,10%TVR) in patients with primary immunodeficiency (PID)

Joseph A. Church,Heinz Leibl,et al.

20050 citations